Hochschulschrift
Caspase-8 deficiency ameliorates hepatic steatosis, but not apoptosis, in a murine model of alcoholic liver disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
21 cm
- Umfang
-
IV, 83 Seiten
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Rheinisch-Westfälische Technische Hochschule Aachen, Dissertation, 2017
- Klassifikation
-
Medizin, Gesundheit
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- [2017]
Ähnliche Objekte (12)
Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro
Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice
l-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice
JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism
Correction to: l-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice
Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice
Alox12/15 deficiency exacerbates, while Lipoxin A4 ameliorates hepatic inflammation in murine alcoholic hepatitis
Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway
Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet
Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro
Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice
l-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice
JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism
Correction to: l-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice
Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice
Alox12/15 deficiency exacerbates, while Lipoxin A4 ameliorates hepatic inflammation in murine alcoholic hepatitis
Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway
Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet
Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro
Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice
Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy
Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice
l-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice
JAZF1 ameliorates age and diet-associated hepatic steatosis through SREBP-1c -dependent mechanism
Correction to: l-Fucose ameliorates high-fat diet-induced obesity and hepatic steatosis in mice
Phloretin ameliorates hepatic steatosis through regulation of lipogenesis and Sirt1/AMPK signaling in obese mice
Alox12/15 deficiency exacerbates, while Lipoxin A4 ameliorates hepatic inflammation in murine alcoholic hepatitis
Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway